Matharu et al. showed that CRISPRa can target endogenous gene regulators (promoter or enhancer) to increase the expression of Sim1, resulting in a rescue of the obesity phenotype in a Sim1 haploinsufficient mouse model [55]. The gene discussed is SIM1; the disease is Obesity.